資源描述:
《原發(fā)性肝癌切除術(shù)后TACE治療的價值-論文.pdf》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在應(yīng)用文檔-天天文庫。
1、254肝膽外科雜志2014年8月第22卷第4期JournalofHepatobiliarySurgery,Vol,22,No.4,A201423PawlikTM,ReyesDK,CosgroveD,KamelIR,BhagatN,Ge—gY/ESMO2013;24(7):1786—92.schwindJF.PhaseIItrialofsorafenibcombinedwithconcurrent27RickeJ,BullaK,KolligsF,eta1.Safetyandtoxicityofradioemboli-transarterialchem
2、oembolizationwithdrug·-elutingbeadsforhepatocel-zationplusSorafenibinadvancedhepatocellularcarcinoma:analysislularcarcinoma.Journalofclinicaloneology:oficialjoumaloftheoftheEuropeanmulticentretrialSORAMIC.Liverintemational:of-AmericanSocietyofClinicalOncology2011;29(30):3960-7
3、.ficialjoumaloftheIntemationalAssociationfortheStudyoftheLiver24Parkjw,KohYH,KimHB,eta1.PhaseIIstudyofconcurrent2014.transarterialchemoembolizationandsorafenibinpatientswithunre—28YoonSM,LimYS,WonHJ,eta1.RadiotherapyplustransarterialsectabIehepatocellularcarcinoma.Journalofhep
4、atolo~2012;56chemoembolizationforhepatocellularcarcinomainvadingtheportal(6):1336—42.vein:long—termpatientoutcomes.Internationaljournalofradiation25IJiY,ZhengYB,ZhaoW,eta1.Sorafenibincombinationwithoncology,biology,physics2012;82(5):2004—11.transarterialchemoembolizationandl?a
5、diofrequencyablationinthe29OgasawaraS,ChibaT,OokaY,eta1.AphaseI/lItrialoftreatmentforunresectablehepatocellularcarcinoma.Medicaloneologycapecitabinecombinedwithpeginterfemnalpha·2ainPatientswith2013;30(4):730.sorafenib—refractoryadvancedhepatocellularcarcinoma.Investigation—26
6、ZhaoY,WangWJ,GuanS,eta1.Sorafenibcombinedwithtransar-alnewdrags2014;32(4):762—8.terialchemoembohzationforthetreatmentofadvancedhepatoeellular(本文編輯耿小平)carcinoma:alarge—scalemultieenterstudyof222patients.Annalsofoncology:officialjoumaloftheEuropeanSocietyforMedicalOncolo-原發(fā)性肝癌切除
7、術(shù)后TACE治療的價值汪名權(quán),張國兵【關(guān)鍵詞】原發(fā)性肝癌,肝動脈化療栓塞術(shù)【中圖分類號】R735.7【文獻標識碼】c【文章編號】1006-4761(2014)04-0254-03原發(fā)性肝癌是全球范圍內(nèi)最常見惡性腫瘤之多中心復(fù)發(fā)也是限制外科手術(shù)及射頻消融的使一用lo]。而全身化療也不適合預(yù)防原發(fā)性肝癌術(shù)后,每年造成大概約50萬人死亡?,同時也是癌癥中第三個常見死亡原因L2J。外科根治切除術(shù)及肝的復(fù)發(fā)?j。TACE術(shù)可以用來治療不可切除的原發(fā)臟移植常常作為原發(fā)性肝癌(Hepatocellularcarcino—性肝癌,也可以用來作為早中期肝癌的治療?,
8、有ma,HCC)的治療方式_3J,但由于缺乏供肝,外科研究u認為可以作為肝癌外科術(shù)后的常規(guī)輔助治根治性切除術(shù)及其他治療方式